Value And Challenges Of Investigating Real-world Effectiveness Of Exercise Physiology Services For Type-2 Diabetes

被引:0
|
作者
Davison, Kade [1 ]
Selig, Steve [2 ]
Parmenter, Belinda [3 ]
Best, Tania [4 ]
Fraiser, Steve [2 ]
Schneider, Silvia [5 ]
Cheney, Michael [6 ]
Hodonu, Jack [6 ]
Pitcher, Christian [7 ]
Furzer, Bonnie [8 ]
Cesnik, Rebecca [9 ]
Hardcastle, Sibella [6 ]
Kitic, Cecilia [6 ]
Williams, Andrew [6 ]
机构
[1] Univ South Australia, Adelaide, SA, Australia
[2] Deakin Univ, Melbourne, Vic, Australia
[3] Univ New South Wales, Sydney, NSW, Australia
[4] Queensland Univ Technol, Brisbane, Qld, Australia
[5] Univ Canberra, Canberra, ACT, Australia
[6] Univ Tasmania, Launceston, Tas, Australia
[7] Australian Catholic Univ, Sydney, NSW, Australia
[8] Univ Western Australia, Perth, WA, Australia
[9] Canberra Hosp, Canberra, ACT, Australia
关键词
D O I
暂无
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
508
引用
收藏
页码:135 / 135
页数:1
相关论文
共 50 条
  • [41] Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study
    Grunberger, George
    Rosenfeld, Cheryl R.
    Bode, Bruce W.
    Abbott, Scott D.
    Nikkel, Carla
    Shi, Leon
    Strange, Poul
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (01) : 31 - 40
  • [42] Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States
    Hankosky, Emily R.
    Desai, Karishma
    Chinthammit, Chanadda
    Grabner, Michael
    Stockbower, Grace
    He, Xuanyao
    Mojdami, Donna
    Wenziger, Cachet
    Gibble, Theresa Hunter
    DIABETES & METABOLISM, 2025, 51 (03)
  • [43] Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain
    Gomez-Peralta, F.
    Lecube, A.
    Fernandez-Marino, A.
    Alonso Troncoso, I.
    Morales, C.
    Morales-Perez, F. M.
    Guler, I.
    Cadarso-Suarez, C.
    DIABETIC MEDICINE, 2018, 35 (11) : 1605 - 1612
  • [44] Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States
    Blonde, Lawrence
    Patel, Charmi
    Wu, Bingcao
    Chen, Yen-Wen
    Pericone, Christopher D.
    Bookhart, Brahim
    ADVANCES IN THERAPY, 2021, 38 (01) : 594 - 606
  • [45] Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment
    Mody, Reema
    Grabner, Michael
    Yu, Maria
    Turner, Ralph
    Kwan, Anita Y. M.
    York, Whitney
    Lando, Laura Fernandez
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 995 - 1003
  • [46] Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes
    Luo, Sihui
    Zheng, Xueying
    Bao, Wei
    Nie, Sheng
    Ding, Yu
    Yue, Tong
    Zhou, Yilun
    Hu, Ying
    Li, Hua
    Yang, Qiongqiong
    Wan, Qijun
    Liu, Bicheng
    Xu, Hong
    Li, Guisen
    Xu, Gang
    Chen, Chunbo
    Liu, Huafeng
    Shi, Yongjun
    Zha, Yan
    Kong, Yaozhong
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    Ji, Linong
    Hou, Fan Fan
    Weng, Jianping
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [47] Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study
    George Grunberger
    Cheryl R. Rosenfeld
    Bruce W. Bode
    Scott D. Abbott
    Carla Nikkel
    Leon Shi
    Poul Strange
    Drugs - Real World Outcomes, 2020, 7 : 31 - 40
  • [48] REAL WORLD EFFECTIVENESS OF DULAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES
    Mody, R.
    Yu, M.
    Fernandez, L.
    Shui, A.
    Kallenbach, L.
    Slipski, L.
    de Oliveira, Piras C.
    VALUE IN HEALTH, 2017, 20 (05) : A164 - A164
  • [49] Value Webs:: Using ontologies to bundle real-world services
    Akkermans, H
    Baida, Z
    Gordijn, J
    Peña, N
    Altuna, A
    Laresgoiti, M
    IEEE INTELLIGENT SYSTEMS, 2004, 19 (04) : 57 - 66
  • [50] Real-world continuous glucose monitoring in adults with type 1 and type 2 diabetes
    Sarri, Grammati
    Zabotka, Luke
    Freitag, Andreas
    Claire, Ravinder
    Wangge, Grace
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 432 - 433